Gremlin-1 activates Akt/STAT3 signaling, which increases the glycolysis rate in breast cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Na Hui | - |
dc.contributor.author | Sung, Nam Ji | - |
dc.contributor.author | Youn, Hyung-Sun | - |
dc.contributor.author | Park, Sin-Aye | - |
dc.date.accessioned | 2021-08-11T08:31:18Z | - |
dc.date.available | 2021-08-11T08:31:18Z | - |
dc.date.issued | 2020-12-17 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.issn | 1090-2104 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2231 | - |
dc.description.abstract | Gremlin-1 (GREM1), one of the antagonists of bone morphogenetic proteins (BMPs), has recently been reported to be overexpressed in a variety of cancers including breast cancer. GREM1 is involved in tumor promotion, but little is known about its role in the glycolysis of cancer cells. In this study, we investigated the role of GREM1 in glycolysis of breast cancer cells and its underlying molecular mechanisms. We first observed that glucose uptake and lactate production were increased in GREM1-overexpressing breast cancer cells. GREM1 increased the expression of hexokinase-2 (HK2), which catalyzes the phosphorylation of glucose, the first step in glycolysis. In addition, GREM1 activated STAT3 transcription factor through the ROS-Akt signaling pathway. The ROS-Akt-STAT3 axis activated by GREM1 was involved in promoting glucose uptake by increasing the expression of HK2 in breast cancer cells. Therefore, our study suggested a new mechanism by which GREM1 is involved in breast cancer promotion by increasing glycolysis in breast cancer cells. (C) 2020 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Academic Press | - |
dc.title | Gremlin-1 activates Akt/STAT3 signaling, which increases the glycolysis rate in breast cancer cells | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.bbrc.2020.10.025 | - |
dc.identifier.scopusid | 2-s2.0-85093659323 | - |
dc.identifier.wosid | 000599699800018 | - |
dc.identifier.bibliographicCitation | Biochemical and Biophysical Research Communications, v.533, no.4, pp 1378 - 1384 | - |
dc.citation.title | Biochemical and Biophysical Research Communications | - |
dc.citation.volume | 533 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1378 | - |
dc.citation.endPage | 1384 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordAuthor | GREM1 | - |
dc.subject.keywordAuthor | Breast cancer | - |
dc.subject.keywordAuthor | Glycolysis | - |
dc.subject.keywordAuthor | HK2 | - |
dc.subject.keywordAuthor | STAT3 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.